Literature DB >> 12853458

Synaptic PDZ domain-mediated protein interactions are disrupted by inhalational anesthetics.

Ming Fang1, Yuan-Xiang Tao, Fahu He, Mingjie Zhang, Claire F Levine, Peizhong Mao, Feng Tao, Chih-Ling Chou, Scheherazade Sadegh-Nasseri, Roger A Johns.   

Abstract

Anesthetics exert multiple effects on the central nervous system through altering synaptic transmission, but the mechanisms for this process are poorly understood. PDZ domain-mediated protein interactions play a central role in organizing signaling complexes around synaptic receptors for efficient signal transduction. We report here that clinically relevant concentrations of inhalational anesthetics dose-dependently and specifically inhibit the PDZ domain-mediated protein interaction between PSD-95 or PSD-93 and the N-methyl-d-aspartate receptor or neuronal nitric-oxide synthase. These inhibitory effects are immediate, potent, and reversible and occur at a hydrophobic peptide-binding groove on the surface of the second PDZ domain of PSD-95 in a manner relevant to anesthetic action. These findings reveal the PDZ domain as a new molecular target for inhalational anesthetics.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12853458     DOI: 10.1074/jbc.M303520200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  The Par-3 NTD adopts a PB1-like structure required for Par-3 oligomerization and membrane localization.

Authors:  Wei Feng; Hao Wu; Ling-Nga Chan; Mingjie Zhang
Journal:  EMBO J       Date:  2007-05-03       Impact factor: 11.598

Review 2.  The Regulation of GluN2A by Endogenous and Exogenous Regulators in the Central Nervous System.

Authors:  Yongjun Sun; Liying Zhan; Xiaokun Cheng; Linan Zhang; Jie Hu; Zibin Gao
Journal:  Cell Mol Neurobiol       Date:  2016-06-02       Impact factor: 5.046

3.  Sensitivity to isoflurane anesthesia increases in autism spectrum disorder Shank3+/∆c mutant mouse model.

Authors:  Changsheng Li; Michele Schaefer; Christy Gray; Ya Yang; Orion Furmanski; Sufang Liu; Paul Worley; C David Mintz; Feng Tao; Roger A Johns
Journal:  Neurotoxicol Teratol       Date:  2016-11-14       Impact factor: 3.763

4.  Effects of Dimeric PSD-95 Inhibition on Excitotoxic Cell Death and Outcome After Controlled Cortical Impact in Rats.

Authors:  Jens Bak Sommer; Anders Bach; Hana Malá; Mikko Gynther; Ann-Sofie Bjerre; Marie Gajhede Gram; Linda Marschner; Kristian Strømgaard; Jesper Mogensen; Darryl S Pickering
Journal:  Neurochem Res       Date:  2017-08-21       Impact factor: 3.996

5.  Early anesthetic exposure and long-term cognitive impairment.

Authors:  Feng Tao
Journal:  World J Exp Med       Date:  2011-12-20

Review 6.  Molecular Mechanisms of Anesthetic Neurotoxicity: A Review of the Current Literature.

Authors:  William M Jackson; Christy D B Gray; Danye Jiang; Michele L Schaefer; Caroline Connor; Cyrus D Mintz
Journal:  J Neurosurg Anesthesiol       Date:  2016-10       Impact factor: 3.956

7.  Nitric Oxide Donor Prevents Neonatal Isoflurane-induced Impairments in Synaptic Plasticity and Memory.

Authors:  Michele L Schaefer; Meina Wang; Patric J Perez; Wescley Coca Peralta; Jing Xu; Roger A Johns
Journal:  Anesthesiology       Date:  2019-02       Impact factor: 7.892

8.  Functional characterization of G-protein-coupled receptors: a bioinformatics approach.

Authors:  L Tovo-Rodrigues; A Roux; M H Hutz; L A Rohde; A S Woods
Journal:  Neuroscience       Date:  2014-07-02       Impact factor: 3.590

9.  Cell-permeable peptide Tat-PSD-95 PDZ2 inhibits chronic inflammatory pain behaviors in mice.

Authors:  Feng Tao; Qingning Su; Roger A Johns
Journal:  Mol Ther       Date:  2008-09-09       Impact factor: 11.454

10.  The volatile anesthetic isoflurane perturbs conformational activation of integrin LFA-1 by binding to the allosteric regulatory cavity.

Authors:  Koichi Yuki; Nathan S Astrof; Clay Bracken; Ronnie Yoo; Whitney Silkworth; Sulpicio G Soriano; Motomu Shimaoka
Journal:  FASEB J       Date:  2008-08-15       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.